| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JNCI/82.15.1264 |
| P698 | PubMed publication ID | 2374176 |
| P50 | author | Richard B Hayes | Q37632158 |
| Linda Williams Pickle | Q102214071 | ||
| Robert N. Hoover | Q118558329 | ||
| P2093 | author name string | Tucker MA | |
| Issaq HJ | |||
| Aisner S | |||
| Buivys D | |||
| Caporaso NE | |||
| Green-Gallo L | |||
| Muschik GM | |||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1264-1272 | |
| P577 | publication date | 1990-08-01 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Lung cancer and the debrisoquine metabolic phenotype | |
| P478 | volume | 82 |
| Q53482353 | A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6. |
| Q37117075 | A tobacco-specific N-nitrosamine or cigarette smoke condensate causes neoplastic transformation of xenotransplanted human bronchial epithelial cells |
| Q47759947 | Activation of procarcinogens by human cytochrome P450 enzymes |
| Q40775719 | Biomarkers and molecular epidemiology of occupationally related cancer |
| Q23922512 | Biomarkers in epidemiology: scientific issues and ethical implications |
| Q34459045 | Candidate gene case-control association studies: advantages and potential pitfalls |
| Q35073279 | Candidate gene case-control studies. |
| Q34843854 | Carcinogen metabolism in human lung tissues and the effect of tobacco smoking: results from a case--control multicenter study on lung cancer patients |
| Q41634342 | Cigaret smoking and the lung |
| Q33602252 | Consensus on synergism between cigarette smoke and other environmental carcinogens in the causation of lung cancer. |
| Q54658015 | Correlation between relatives for colorectal cancer mortality in familial adenomatous polyposis. |
| Q68327258 | Detection of DNA sequence polymorphisms in carcinogen metabolism genes by polymerase chain reaction |
| Q41096228 | Effect of cohort differences in smoking prevalence on models of lung cancer susceptibility |
| Q33703714 | Gene environment interaction |
| Q33899650 | Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in black Americans |
| Q37698407 | Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): Population distribution of CYP2D6 activity |
| Q34582043 | Genetic polymorphisms and metabolism of endocrine disruptors in cancer susceptibility |
| Q40902474 | Genetic polymorphisms in human drug-metabolizing enzymes: potential uses of reverse genetics to identify genes of toxicological relevance |
| Q41828306 | Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility. |
| Q23919906 | Gestational mutations and carcinogenesis |
| Q41702059 | Individualization of cancer therapy based on cytochrome P450 polymorphism: a pharmacogenetic approach |
| Q41561466 | Interaction between dose and susceptibility to environmental cancer: a short review |
| Q34405282 | Mapping out a search for environmental causes of breast cancer. |
| Q67919493 | Metabolism of debrisoquine and susceptibility to breast cancer |
| Q42428766 | Modulation of DNA binding in vivo by specific humoral immunological response: a novel host factor in environmental carcinogenesis? |
| Q34844253 | Molecular genetic analysis of the cytochrome P450-debrisoquine hydroxylase locus and association with cancer susceptibility |
| Q40931793 | Molecular genetics of cytochrome P450 IID. Anomalies of drug metabolism |
| Q36827597 | Molecular mechanisms in lung pathogenesis |
| Q44191218 | Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients |
| Q36929920 | P450 and Human Cancer |
| Q33781271 | Pharmacogenetics of cytochromes P450. |
| Q28767825 | Pharmacogenetics: detecting sensitive populations |
| Q35275607 | Polymerase chain reaction and its potential as a pharmacokinetic tool |
| Q67593712 | Prediction of phenotype for acetylation and for debrisoquine hydroxylation by DNA-tests in healthy human volunteers |
| Q33864869 | Predisposition to lung tumorigenesis |
| Q33533986 | Recent advances in understanding the molecular basis of polymorphisms in genes encoding cytochrome P450 enzymes. |
| Q34844001 | Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis |
| Q35031116 | Statistical models for genetic susceptibility in toxicological and epidemiological investigations |
| Q40700833 | Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite |
| Q89666661 | The Molecular Mechanism of Metabolic Remodeling in Lung Cancer |
| Q34843826 | The debrisoquine metabolic phenotype and DNA-based assays: implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotype |
| Q40870692 | The etiology of lung cancer |
| Q41777493 | The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer |
| Q41570913 | The molecular epidemiology of lung cancer |
| Q43448607 | The place of human values in the language of science: Kuhn, Saussure, and structuralism |
| Q52892865 | The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of lung cancer: a meta-analysis. |
| Q38506876 | United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females |
| Q23919246 | Use of biomarkers to investigate occupational and environmental lung disorders |
| Q39667563 | Women and small cell lung cancer: social characteristics, medical history, management and survival: a retrospective study of all the male and female cases diagnosed in Bas-Rhin (Eastern France) between 1981 and 1994. |
Search more.